← All Sponsors
SPONSOR

RenJi Hospital

Total Trials
11
Recruiting
11
Phases
Phase 2, Phase 3

RenJi Hospital is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Epidural Hematoma, Decompressive Craniectomy, Craniotomy, Oligometastatic Prostate Cancer.

The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — RenJi Hospital

How many clinical trials has RenJi Hospital sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by RenJi Hospital, of which 11 are actively recruiting participants. These trials cover conditions including Epidural Hematoma, Decompressive Craniectomy, Craniotomy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does RenJi Hospital research focus on?
RenJi Hospital clinical trials span Epidural Hematoma, Decompressive Craniectomy, Craniotomy, Oligometastatic Prostate Cancer, Public Health, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a RenJi Hospital clinical trial?
To participate in a RenJi Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all RenJi Hospital trials with current recruitment status updated daily.

Clinical Trials by RenJi Hospital

NCT04229966
Recruiting

Prospective, Observational Real-world Treatments of AEDH in Large-scale Surgical Cases

Epidural Hematoma
NCT06972511 Phase 2, Phase 3
Recruiting

Maximal Tumor Eradication for Oligometastatic Prostate Cancer

Oligometastatic Prostate Cancer
NCT06924580
Recruiting

Early ECG Prediction of Multi-system Disease Cohort Establishment and Follow Up

Public Health
NCT05795335
Recruiting

CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer

Breast Cancer
NCT05926726
Recruiting

GPC3-directed CAR-T in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma
NCT05894863
Recruiting

Smart Flex Stent System for the Treatment Long Femoropopliteal Artery Lesions

Peripheral Arterial Disease
NCT05967663
Recruiting

Fractional Flow Reserve Guided Immediate Versus Staged Complete Myocardial Revascularization in Patients With ST-segment Elevation Myocardial Infarction With Multivessel Disease (Future Study)

ST Elevation Myocardial Infarction
NCT06994221
Recruiting

Fibrosis Assessment in Myocardial Infarction-associated Ventricular Aneurysm

Acute Myocardial Infarction
NCT05326399
Recruiting

Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment

Liver Transplantation
NCT05416684
Recruiting

Prospective Observational Study on Comprehensive Effects of PEEK Cranioplasty and Titanium Cranioplasty After DC(RECEPT-DC)

Skull Defect
NCT07574398
Recruiting

A Survey on Growth Development in Children After Liver Transplantation

Growth, Development in Pediatric Liver Transplant Recipients
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology